Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
Company profile
Ticker
AMBS
Exchange
Website
CEO
Gerald E. Commissiong
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Amarantus Bioscience, Inc., Amarantus BioSciences, Inc., Jumpkicks, Inc.
SEC CIK
Corporate docs
AMBS stock data
Latest filings (excl ownership)
SEC STAFF ACTION
SEC staff action: Order
9 Sep 22
1-A-W
Offering statement withdrawal
10 Jan 20
1-A/A
Offering $5M in Equity
9 Jan 20
1-A
Offering $5M in Equity
9 Jan 20
1-A
Offering $5M in Equity
27 Sep 19
DOS
Draft offering statement (non-public)
27 Nov 18
D
$1.5M in equity / options / securities to be acquired, sold $300K, 1 investor
12 Mar 18
15-12G
Securities registration termination
4 Dec 17
8-K
Departure of Directors or Certain Officers
9 May 17
8-K
Entry into a Material Definitive Agreement
17 Apr 17
Latest ownership filings
SC 13D/A
Anson Funds Management LP
18 Apr 22
SC 13D/A
Dominion Capital L.L.C.
18 Apr 22
SC 13D/A
Lorient Ventures Ltd
18 Apr 22
SC 13D
Lorient Ventures Ltd
9 Oct 20
SC 13D
Dominion Capital L.L.C.
5 Oct 20
SC 13D
Anson Funds Management LP
5 Oct 20
4
Rongguo Wei
6 Nov 17
4
Conn Flanigan
15 May 17
4
ROBERT H TRAPP
5 May 17
3
Steven Spence
6 Apr 17
Institutional ownership, Q4 2021
4.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 270.00 k |
Total shares | 28.35 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Dominion Capital L.L.C. | 14.18 mm | $135.00 k |
Lorient Ventures | 14.18 mm | $135.00 k |